Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37351 - 37375 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	GPSM3	63940	upregulated	entinostat results in increased expression of GPSM3 mRNA	6p21.32	A21035
Entinostat	Investigational	GRAMD1C	54762	upregulated	entinostat results in increased expression of GRAMD1C mRNA	3q13.31	A21035
Entinostat	Investigational	GRAMD2	196996	upregulated	entinostat results in increased expression of GRAMD2 mRNA	15q23	A21035
Entinostat	Investigational	GRAMD3	65983	upregulated	entinostat results in increased expression of GRAMD3 mRNA	5q23.2	A21035
Entinostat	Investigational	GRB14	2888	upregulated	entinostat results in increased expression of GRB14 mRNA	2q24.3	A21037
Entinostat	Investigational	GREM1	26585	upregulated	entinostat results in increased expression of GREM1 mRNA	15q13.3	A21037
Entinostat	Investigational	GREM2	64388	downregulated	entinostat results in decreased expression of GREM2 mRNA	1q43	A21035
Entinostat	Investigational	GRIA1	2890	downregulated	entinostat results in decreased expression of GRIA1 mRNA	5q33.2	A21037
Entinostat	Investigational	GRIN2A	2903	upregulated	entinostat results in increased expression of GRIN2A mRNA	16p13.2	A21037
Entinostat	Investigational	GRIP1	23426	downregulated	entinostat results in decreased expression of GRIP1 mRNA	12q14.3	A21035
Entinostat	Investigational	GRK6	2870	upregulated	entinostat results in increased expression of GRK6 mRNA	5q35.3	A21037
Entinostat	Investigational	GRM2	2912	downregulated	entinostat results in decreased expression of GRM2 mRNA	3p21.2	A21035
Entinostat	Investigational	GRP	2922	downregulated	entinostat results in decreased expression of GRP mRNA	18q21.32	A21037
Entinostat	Investigational	GSE1	23199	upregulated	entinostat results in increased expression of GSE1 mRNA	16q24.1	A21037
Entinostat	Investigational	GSK3B	2932	downregulated	entinostat results in decreased expression of GSK3B mRNA	3q13.33	A21037
Entinostat	Investigational	GSN	2934	upregulated	entinostat results in increased expression of GSN mRNA	9q33.2	A21035
Entinostat	Investigational	GSTO2	119391	upregulated	entinostat results in increased expression of GSTO2 mRNA	10q25.1	A21035
Entinostat	Investigational	GSX1	219409	downregulated	entinostat results in decreased expression of GSX1 mRNA	13q12.2	A21035
Entinostat	Investigational	GTF2IRD2	84163	downregulated	entinostat results in decreased expression of GTF2IRD2 mRNA	7q11.23	A21035
Entinostat	Investigational	GTSF1	121355	upregulated	entinostat results in increased expression of GTSF1 mRNA	12q13.13	A21035
Entinostat	Investigational	GUCA1A	2978	upregulated	entinostat results in increased expression of GUCA1A mRNA	6p21.1	A21035
Entinostat	Investigational	GUCY1A2	2977	downregulated	entinostat results in decreased expression of GUCY1A2 mRNA	11q22.3	A21035
Entinostat	Investigational	GUCY1B3	2983	downregulated	entinostat results in decreased expression of GUCY1B3 mRNA	4q32.1	A21037
Entinostat	Investigational	GUSBP3	653188	downregulated	entinostat results in decreased expression of GUSBP3 mRNA	5q13.2	A21035
Entinostat	Investigational	H2AFJ	55766	upregulated	entinostat results in increased expression of H2AFJ mRNA	12p12.3	A21035

Displaying entries 37351 - 37375 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability